Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-514-5 | CAS number: 107-71-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1978-08-23 and 1978-12-15
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study without detailed documentation
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 978
- Report date:
- 1978
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- yes
- Remarks:
- 2 animals per doses per sex
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- tert-butyl peracetate
- EC Number:
- 203-514-5
- EC Name:
- tert-butyl peracetate
- Cas Number:
- 107-71-1
- Molecular formula:
- C6H12O3
- IUPAC Name:
- tert-butyl ethaneperoxoate
Constituent 1
Test animals
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: H.A.R.E. Rabbits for Research, Hewitt, New Jersey
- Weight at study initiation: 2304 to 2863 grams
- Housing: individually housed in hanging wire-mesh cages
- Diet: Purina® Rabbit Chow®; ad libitum
- Water: ad libitum
- Acclimation period: 19 days
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- not specified
- Details on dermal exposure:
- TEST SITE
The hair was removed from the back of each rabbit (20-30% of the body surface) with an electric clipper. The skin of one male and one female in each group was abraded with a scalpel blade by making 10 cm long epidermal abrasions every 2 or 3 cm longitudinally over the area of exposure. Following dosing, the application sites were wrapped with gauze bandaging and overwrapped with Saran Wrap. The entire application area was then wrapped with several layers of 75 mm Elastoplast tape. A collar was also applied.
REMOVAL OF TEST SUBSTANCE
- 24-h following application, the bandages and collars were removed and the test sites were wiped clean - Duration of exposure:
- 24 hours
- Doses:
- 500, 1000, 2000, 4000, 8000 and 16000 mg/kg
- No. of animals per sex per dose:
- 2
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: rabbits were observed for mortality twice daily for a total of 14 days
- Frequency of weighing: immediately prior to test material administration (control weight) and at 7 and 14 days of the observation period - Statistics:
- 95% confidence limits
Results and discussion
Effect levelsopen allclose all
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 4 000 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 2 000 - 8 000
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 5 657 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 2 828 - 11 314
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 4 757 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 3 364 - 6 727
- Mortality:
- Please refer to Table 1 ("Any other information on results incl tables")
- Body weight:
- other body weight observations
- Remarks:
- The body weight gain of two females was slightly reduced between day 7 and 14. Two other females lost weight between day 1 and 14. One male showed a very slight lost of weight between day 1 and 7. The body weights of all animals are shown in Table 2 (refer to "Any other information on results incl tables").
Any other information on results incl. tables
Table 1 shows the number of deaths during the observation period.
Table 1: Summary of Mortality
Time of observation | Number of Deaths | |||||||||||
Dosage Level (mg/kg) | ||||||||||||
500 | 1000 | 2000 | 4000 | 8000 | 16000 | |||||||
M | F | M | F | M | F | M | F | M | F | M | F | |
Day 1 |
|
|
|
|
|
|
|
| 2 | 1 | 2 | 1 |
Day 2 |
|
|
|
|
|
| 1 |
|
| 1 |
|
|
Day 3 -14 |
|
|
|
|
|
|
|
|
|
|
|
|
Total | 0/2 | 0/2 | 0/2 | 0/2 | 0/2 | 0/2 | 1/2 | 0/2 | 2/2 | 2/2 | 2/2 | 2/2 |
M: male
F: female
Table 2 shows the body weights obtained during the observation period.
Table 2: Summary of body weight measurements
Dosage Level (mg/kg) | Animal + Sex | Control Weight (g) | 7 Day Weight (g) | 14 Day Weight (g) |
500 | 01 Male | 2304 | 2441 | 2841 |
02 Male | 2512 | 2668 | 2761 | |
01 Female | 2525 | 2731 | 3088 | |
02 Female | 2852 | 2939 | 3131 | |
1000 | 03 Male | 2545 | 2706 | 2841 |
04 Male | 2429 | 2442 | 2530 | |
03 Female | 2693 | 2732 | 2611 | |
04 Female | 2485 | 2505 | 2981 | |
2000 | 05 Male | 2310 | 2421 | 2733 |
06 Male | 2863 | 2841 | 2889 | |
05 Female | 2742 | 2886 | 2863 | |
06 Female | 2358 | 2205 | 1971 | |
4000 | 07 Male | 2470 | 2460 | 2581 |
08 Male | 2320 | died | died | |
07 Female | 2633 | 2565 | 2911 | |
08 Female | 2569 | 2211 | 2423 | |
8000 | 09 Male | 2480 | died | died |
10 Male | 2402 | died | died | |
09 Female | 2451 | died | died | |
10 Female | 2325 | died | died | |
16000 | 11 Male | 2326 | died | died |
12 Male | 2467 | died | died | |
11 Female | 2310 | died | died | |
12 Female | 2308 | died | died |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Based upon the data obtained, the acute dermal LD50 values and 95% confidence limits for the test material (75% active ingredient) were calculated to be as follows: Male Rabbits: 4000 (2000 - 8000) mg/kg bw, Female Rabbits: 5657 (2828 - 11314) mg/kg bw, Combined Male and Female Rabbits: 4757 (3364 - 6727) mg/kg bw. Based on the mixture containing 50% of the active ingredient the dermal LC50 values are expected to be 6000 mg/kg bw (males), 8485.5 mg/kg bw (females) and 7135.5 mg/kg bw (combined male and female).
- Executive summary:
An acute dermal toxicity study was performed in 12 male and 12 female New Zealand White rabbits obtained from H.A.R.E. Rabbits for Research, Hewitt, New Jersey.They were individually housed in hanging wire-mesh cages and water and diet were available ad libitum. The rabbits were divided into six groups of two male and two female rabbits each. The test material (75% active ingredient) was applied once only to the backs of the rabbits at the following dosage levels: 500, 1000, 2000, 4000, 8000 and 16000 mg/kg bw. Following dosing, the application sites were wrapped with gauze bandaging and overwrapped with Saran Wrap. The entire application area was then wrapped with several layers of 75 mm Elastoplast tape. The animals were durated for 24 hours. The mortality was checked twice daily for a period of 14 days. The body weight gain were recorded immediately prior to test material (control weight) and on day 7 and 14.
Based upon the data obtained, the acute dermal LD50 values and 95% confidence limits were calculated to be as follows: Male Rabbits: 4000 (2000 - 8000) mg/kg bw, Female Rabbits: 5657 (2828 - 11314) mg/kg bw, Combined Male and Female Rabbits: 4757 (3364 - 6727) mg/kg bw. Based on the mixture containing 50% of the active ingredient the dermal LC50 values are expected to be 6000 mg/kg bw (males), 8485.5 mg/kg bw (females) and 7135.5 mg/kg bw (combined male and female).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.